We are live on ! Find out more
CIP

Chartwell Investment Partners Portfolio holdings

AUM $2.91B
1-Year Est. Return 40.48%
This Fund
S&P 500
This Quarter Est. Return
+10.36%
1 Year Est. Return
+40.48%
3 Year Est. Return
+57.16%
5 Year Est. Return
+148.97%
10 Year Est. Return
+397.87%
AUM
$3.44B
AUM Growth
+$225M
Cap. Flow
-$55.1M
Cap. Flow %
-1.6%
Top 10 Hldgs %
13.72%
Holding
457
New
29
Increased
62
Reduced
284
Closed
34

Top Buys

Rank Stock Value
1
VC icon
Visteon
VC
+$15.3M
2
QCOM icon
Qualcomm
QCOM
+$6.79M
3
CMCO icon
Columbus McKinnon
CMCO
+$5.89M
4
CVS icon
CVS Health
CVS
+$5.8M
5
IBM icon
IBM
IBM
+$5.73M

Top Sells

Rank Stock Value
1
CF icon
CF Industries
CF
+$10.4M
2
LMT icon
Lockheed Martin
LMT
+$8.81M
3
CSCO icon
Cisco
CSCO
+$6.28M
4
PYPL icon
PayPal
PYPL
+$6.14M
5
MSFT icon
Microsoft
MSFT
+$6.02M

Sector Composition

Rank Sector Weight
1 Technology 20.28%
2 Financials 16.52%
3 Industrials 12.39%
4 Consumer Discretionary 11.85%
5 Healthcare 11.39%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SWKS icon
401
Skyworks Solutions
SWKS
$10.5B
$537K 0.02%
3,461
IGSB icon
402
iShares 1-5 Year Investment Grade Corporate Bond ETF
IGSB
$23.3B
$529K 0.02%
9,825
+4,510
+85% +$244K
TRU icon
403
TransUnion
TRU
$15.2B
$477K 0.01%
4,020
KURA icon
404
Kura Oncology
KURA
$854M
$476K 0.01%
33,992
-848
-2% -$13.7K
ALLO icon
405
Allogene Therapeutics
ALLO
$704M
$474K 0.01%
31,781
+10,915
+52% +$193K
STE icon
406
Steris
STE
$23B
$467K 0.01%
1,919
CRDF icon
407
Cardiff Oncology
CRDF
$77M
$466K 0.01%
+77,607
New +$463K
AGG icon
408
iShares Core US Aggregate Bond ETF
AGG
$138B
$464K 0.01%
4,070
TFX icon
409
Teleflex
TFX
$5.95B
$452K 0.01%
1,375
-7,774
-85% -$2.65M
PHAT icon
410
Phathom Pharmaceuticals
PHAT
$691M
$437K 0.01%
22,194
-395
-2% -$9.3K
SRRK icon
411
Scholar Rock
SRRK
$6.23B
$416K 0.01%
16,730
-320
-2% -$8.83K
SLQD icon
412
iShares 0-5 Year Investment Grade Corporate Bond ETF
SLQD
$2.38B
$404K 0.01%
7,910
AFMD
413
DELISTED
Affimed
AFMD
$369K 0.01%
6,677
-122
-2% -$7.54K
J icon
414
Jacobs Solutions
J
$17.1B
$231K 0.01%
2,008
+28
+1% +$3.24K
TPTX
415
DELISTED
Turning Point Therapeutics, Inc. Common Stock
TPTX
$218K 0.01%
4,570
-148
-3% -$6.62K
IWM icon
416
iShares Russell 2000 ETF
IWM
$81.5B
$214K 0.01%
961
PTCT icon
417
PTC Therapeutics
PTCT
$6.14B
$212K 0.01%
5,327
-173
-3% -$6.62K
ALXO icon
418
ALX Oncology
ALXO
$290M
-5,290
Closed -$391K
ANSS
419
DELISTED
Ansys
ANSS
-1,234
Closed -$420K
ARGX icon
420
argenx
ARGX
$55.2B
-1,939
Closed -$586K
AZTA icon
421
Azenta
AZTA
$1.51B
-6,677
Closed -$683K
BBIO icon
422
BridgeBio Pharma
BBIO
$16.6B
-16,276
Closed -$763K
VISN
423
Vistance Networks Inc
VISN
$2.6B
-144,949
Closed -$1.97M
CVNA icon
424
Carvana
CVNA
$80.1B
-38,110
Closed -$2.3M
DIN icon
425
Dine Brands
DIN
$429M
-15,840
Closed -$1.29M

Similar funds

Chartwell Investment Partners's Q4 2021 Portfolio in Review

As of Q4 2021, Chartwell Investment Partners held 457 positions worth $3.44B, up 7% from $3.21B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

Chartwell Investment Partners's Q4 2021 filing shows 29 new, 62 increased, 284 reduced and 34 closed positions. Its largest new stake was Visteon: 137,624 shares worth $15.3M. The largest sale was CF Industries, an estimated $10.4M.

By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 19% a quarter earlier, followed by Financials and Industrials.

  • Chartwell Investment Partners's largest Q4 2021 buy was Visteon: 137,624 shares worth $15.3M.
  • Chartwell Investment Partners added most to Columbus McKinnon in Q4 2021, an estimated $5.89M increase.
  • Chartwell Investment Partners's biggest Q4 2021 reduction was CF Industries, cutting an estimated $10.4M.
  • Chartwell Investment Partners fully exited Saia in Q4 2021, selling an estimated $5.35M.
  • Chartwell Investment Partners's ten largest holdings make up 14% of its $3.44B portfolio in Q4 2021.
  • Chartwell Investment Partners opened 29 new positions and closed 34 in Q4 2021.
  • Chartwell Investment Partners's portfolio value rose 7% quarter-over-quarter to $3.44B.

Based on Chartwell Investment Partners's 13F filing for Q4 2021, filed 15 Feb 2022.